PubMed

Periorbital dermatitis as a side effect of topical dorzolamide.

Delaney YM, Salmon JF, Mossa F, Gee B, Beehne K, Powell S.

Br J Ophthalmol. 2002 Apr;86(4):378-80.PMID: 11914202 [PubMed - indexed for MEDLINE]Related articlesFree article

[Postoperative behavior of intraocular pressure after posterior Nd:YAG laser capsulotomy--critical evaluation in preventive administration of local carbonic anhydrase II inhibitor dorzolamide hydrochloride (Trusopt)]

Lachmann C, Jörg KM, Trinkmann R.

Klin Monbl Augenheilkd. 1998 Dec;213(6):326-30. German. PMID: 10048009 [PubMed - indexed for MEDLINE]Related articles

Lichenoid drug eruption secondary to topical timolol and dorzolamide eye-drops.

Mullins RJ, Lones R, Dutta B.

Australas J Dermatol. 2004 May;45(2):151-2. No abstract available. PMID: 15068470 [PubMed - indexed for MEDLINE]Related articles

Irreversible corneal decompensation in patients treated with topical dorzolamide.

Konowal A, Morrison JC, Brown SV, Cooke DL, Maguire LJ, Verdier DV, Fraunfelder FT, Dennis RF, Epstein RJ.

Am J Ophthalmol. 1999 Apr;127(4):403-6.PMID: 10218692 [PubMed - indexed for MEDLINE]Related articles

Erythema multiforme after use of topical dorzolamide.

Munshi V, Ahluwalia H.

J Ocul Pharmacol Ther. 2008 Feb;24(1):91-3.PMID: 18370879 [PubMed - indexed for MEDLINE]Related articles

A 3-month randomized controlled trial of bimatoprost (LUMIGAN) versus combined timolol and dorzolamide (Cosopt) in patients with glaucoma or ocular hypertension.

Coleman AL, Lerner F, Bernstein P, Whitcup SM.

Ophthalmology. 2003 Dec;110(12):2362-8.PMID: 14644719 [PubMed - indexed for MEDLINE]Related articles

A randomized trial assessing dorzolamide in patients with glaucoma who are younger than 6 years.

Ott EZ, Mills MD, Arango S, Getson AJ, Assaid CA, Adamsons IA.

Arch Ophthalmol. 2005 Sep;123(9):1177-86.PMID: 16157797 [PubMed - indexed for MEDLINE]Related articles

Comparing the fixed combination dorzolamide-timolol (Cosopt) to concomitant administration of 2% dorzolamide (Trusopt) and 0.5% timolol -- a randomized controlled trial and a replacement study.

Francis BA, Du LT, Berke S, Ehrenhaus M, Minckler DS; Cosopt Study Group.

J Clin Pharm Ther. 2004 Aug;29(4):375-80.PMID: 15271105 [PubMed - indexed for MEDLINE]Related articles

Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata.

Wirtitsch MG, Findl O, Kiss B, Petternel V, Heinzl H, Drexler W.

Arch Ophthalmol. 2003 May;121(5):621-5.PMID: 12742838 [PubMed - indexed for MEDLINE]Related articles

Hypotony and choroidal effusion induced by topical timolol and dorzolamide in patients with previous glaucoma drainage device implantation.

Callahan C, Ayyala RS.

Ophthalmic Surg Lasers Imaging. 2003 Nov-Dec;34(6):467-9.PMID: 14620750 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of dose escalation of dorzolamide used in combination with other topical antiglaucoma agents.

Araie M, Kitazawa Y, Azuma I, Shirato S, Hamanaka T, Tomita G, Origasa H.

J Ocul Pharmacol Ther. 2003 Dec;19(6):517-25.PMID: 14733709 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of topical brinzolamide and dorzolamide when added to the combination therapy of latanoprost and a beta-blocker in patients with glaucoma.

Tsukamoto H, Noma H, Matsuyama S, Ikeda H, Mishima HK.

J Ocul Pharmacol Ther. 2005 Apr;21(2):170-3.PMID: 15857284 [PubMed - indexed for MEDLINE]Related articles

Drug-induced ectropion: what is best practice?

Hegde V, Robinson R, Dean F, Mulvihill HA, Ahluwalia H.

Ophthalmology. 2007 Feb;114(2):362-6.PMID: 17270684 [PubMed - indexed for MEDLINE]Related articles

[Efficiency of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers]

Carrasco Font C, Arias Puente A, García Sáenz MC, Villarejo Díaz-Maroto I.

Arch Soc Esp Oftalmol. 2004 Apr;79(4):163-8. Spanish. PMID: 15124072 [PubMed - indexed for MEDLINE]Related articlesFree article

Experience with Cosopt, the fixed combination of timolol and dorzolamide, after switch from free combination of timolol and dorzolamide, in Swiss ophthalmologists' offices.

Gugleta K, Orgül S, Flammer J.

Curr Med Res Opin. 2003;19(4):330-5.PMID: 12841926 [PubMed - indexed for MEDLINE]Related articles

Allergic contact dermatitis from timolol and dorzolamide eye drops.

Kalavala M, Statham BN.

Contact Dermatitis. 2006 Jun;54(6):345. No abstract available. PMID: 16787459 [PubMed - indexed for MEDLINE]Related articles

Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.

Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.

Ophthalmology. 2003 Mar;110(3):615-24.PMID: 12623832 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT) versus 0.005% (XALATAN) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials.

Fechtner RD, Airaksinen PJ, Getson AJ, Lines CR, Adamsons IA; COSOPT versus XALATAN Study Groups.

Acta Ophthalmol Scand. 2004 Feb;82(1):42-8.PMID: 14982045 [PubMed - indexed for MEDLINE]Related articles

Brimonidine purite 0.15% versus dorzolamide 2% each given twice daily to reduce intraocular pressure in subjects with open angle glaucoma or ocular hypertension.

Sharpe ED, Day DG, Beischel CJ, Rhodes JS, Stewart JA, Stewart WC.

Br J Ophthalmol. 2004 Jul;88(7):953-6.PMID: 15205246 [PubMed - indexed for MEDLINE]Related articlesFree article

Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.

Susanna R Jr, Sheu WP; Latin American Glaucoma Society.

Clin Ther. 2004 May;26(5):755-68.PMID: 15220019 [PubMed - indexed for MEDLINE]Related articles